Recent Updates
Recently added Catalysts
NAUT Positive Sentiment

Nautilus in the News – GenomeWeb: Nautilus Proteomics Platform Could Bring New Depth to Proteoform Analyses

Thursday, December 5, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Nautilus presented innovative tau proteoform data at the HUPO 2024 conference, as reported by GenomeWeb. Experts Neil Kelleher and Sally Temple discussed the significant implications of this new data for proteoform analyses. Temple, who is also a collaborator with Nautilus, emphasized the transformative potential of these findings in the field.
Price reaction · baseline $1.9237 (2024-12-05T20:48:00.000Z) · hit during market hours · 1 other NAUT headline(s) in the window, move may be shared
day 0 close · peak
-0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Nautilus shared novel tau proteoform data at HUPO 2024.
  • Experts highlight the potential of the new data for proteoform analyses.
  • Collaboration with prominent scientists enhances credibility.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~29 mo
Minimal dilution risk
Lead asset
MDMA
Phase 2 · Post-Traumatic Stress Disorder

Full Press Release Details

Nautilus in the News
December 5, 2024
In this GenomeWeb piece, Adam Bonislawski summarizes novel tau proteoform data shared by Nautilus at HUPO 2024. The piece features comments from Neil Kelleher, Northwestern Professor, and Sally Temple, Scientific Director at the Neural Stem Cell Institute. They provide great perspectives on the potential power provided by this new kind of data. Temple is also a Nautilus collaborator.
Read the full piece here.
Share this Article
Stay up-to-date on all things Nautilus
World-class articles, delivered weekly
MORE ARTICLES
Nautilus in the news – Why proteins may help solve existential crises in healthcare, food security, and climate
Read more
Nautilus in the news – Scale Remains Key Challenge for Single-Molecule Protein Technologies
Read more
Nautilus in the news – New Proteomic Technologies Firms Leading With Targeted Analyses
Read more
Stay up-to-date on all things Nautilus

Subscribe to our Newsletter

Frequently Asked Questions

What data did Nautilus present at HUPO 2024?

Nautilus presented novel tau proteoform data at the HUPO 2024 conference.

Who commented on Nautilus's data?

Neil Kelleher and Sally Temple provided insights on the data's potential.

What is Sally Temple's role with Nautilus?

Sally Temple is a Scientific Director and a collaborator with Nautilus.

Where can I read more about Nautilus's news?

You can find more articles and updates on Nautilus's official channels.

ShareAdd on Google
Tags: NAUT Viatris Investor Conferences Healthcare Nautilus proteomics tau proteoform HUPO 2024 Neil Kelleher
Last updated: Dec 5, 2024

Biotech snapshot

Cash runway
$143M liquidity · $4M/mo burn
~29 mo
Minimal dilution risk
Lead asset
MDMAPhase 2
Post-Traumatic Stress Disorder →